LifeStance Therapists & Psychiatrists Grand Rapids
3950 Sparks Drive Southeast, Suite 103, Grand Rapids
4.6(285 Google reviews)
United States
5 listed treatment centers serving Grand Rapids and the surrounding area.
3950 Sparks Drive Southeast, Suite 103, Grand Rapids
4.6(285 Google reviews)
3950 Sparks Drive Southeast, Suite 103, Grand Rapids
5.0(57 Google reviews)
For people in Grand Rapids, the cost of SPRAVATO® depends on insurance benefits, the treatment setting, and the services billed. Both the medication and the visit for supervised administration and monitoring may generate charges. Ask for an estimate covering both—not just the nasal spray—and confirm it with your insurer.
Prior authorization is common. Your insurer may request records of earlier antidepressant trials, including which medications you tried and how you responded. Ask the treatment center what documentation it needs from your current or previous prescribers, who submits the authorization request, and how you will learn the decision. An evaluation does not guarantee insurance approval.
Medicare coverage may fall under Part B or Part D, depending on the plan and setting. Michigan Medicaid coverage also depends on the plan and treatment setting. Do not assume that a directory listing means a center accepts either program; verify participation and coverage directly.
Manufacturer savings programs exist for eligible commercially insured patients, but not for people using government insurance. Eligibility restrictions apply. Ask whether you qualify and which charges assistance may cover; it may not address every part of the visit.
Before starting, ask the center and insurer:
Include transportation and time away from work in your planning, even though they are separate from medical charges.
SPRAVATO® treatment takes place only in a healthcare setting certified through the SPRAVATO® REMS program. You administer the nasal spray yourself under direct observation; it is never sent home. Before scheduling, confirm the location’s current certification and whether it is accepting new patients. A directory listing alone does not verify certification.
For treatment-resistant depression, the typical labeled schedule starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Maintenance may continue weekly or every two weeks. Your prescriber individualizes the schedule; these intervals are not a promise of your personal treatment plan.
Plan for at least two hours of monitoring after each dose, plus any check-in, preparation, and discharge time. Ask the center how much time to reserve rather than assuming the entire appointment will fit into two hours. If you work, discuss recurring appointment time and transportation needs before your first dose. Consider whether you need time off rather than planning to return immediately to safety-sensitive duties.
You need someone else to drive you home. Do not drive or operate machinery until the next day after a restful sleep. Arrange a reliable ride for every appointment and a backup option. Ask the center about its pickup requirements before relying on a taxi or rideshare service.
If no Grand Rapids center is listed when you search, or local options cannot accommodate you, expand your search to listed locations such as Marne, Kalamazoo, or Lansing. Confirm certification, appointment availability, and insurance participation directly. Compare the full round-trip transportation commitment before choosing a location.
Use the directory as a starting point, then contact the location directly to confirm that it is currently certified through the SPRAVATO® REMS program. Certification is not confirmed in the supplied local listings. Also ask whether the location accepts new patients and your insurance. If Grand Rapids options do not work for you, you can check listed locations in Marne, Kalamazoo, or Lansing.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder and acute suicidal ideation or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, treatment history, and health risks to determine whether it is appropriate; meeting an approved indication does not guarantee eligibility.
Coverage depends on your plan and the treatment setting. Prior authorization and records of earlier antidepressant trials are common requirements. Medicare coverage may involve Part B or Part D; Michigan Medicaid coverage also varies by plan. Ask both the center and insurer about the medication, monitoring visit, network status, and your share of charges. A listing does not establish insurance participation or guarantee payment.
You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours after the dose, including watching for sedation, dissociation, breathing problems, and blood pressure increases. Allow extra time for preparation and discharge. Arrange someone else to drive you home, and do not drive until the next day after a restful sleep.
Spravato carries boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. Dissociation can feel like being disconnected from yourself or your surroundings. Blood pressure can also increase. It is a Schedule III controlled substance. Tell your clinician about your health history, medications, and substance use so they can assess risks. Report concerning symptoms to staff during your visit.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Do not wait for a treatment appointment if you need urgent help. Call or text 988 for crisis support, or call 911 in an emergency. A clinician can help determine the appropriate level of care alongside any discussion of depression treatment.
Approved uses, nearby treatment centers, and medically sourced patient guides.